Leeds Vascular Institute, The General Infirmary at Leeds, Great George Street, Leeds LS1 3EX, UK.
J Vasc Interv Radiol. 2011 Feb;22(2):163-7. doi: 10.1016/j.jvir.2010.10.018.
The optimal treatment for type II endoleaks remains unclear. The present report describes a case of ischemic skin ulceration after glue embolization of a type II endoleak with challenging access in a multiply comorbid 82-year-old woman with an expanding aneurysm sac 3 years after endovascular aneurysm repair. Embolization was performed from a proximal position with an n-butyl cyanoacrylate/Ethiodol mixture to allow flow into the endoleak because direct sac puncture was hazardous. One week after intervention, an eschar, which progressed to superficial necrosis as a result of partial nontarget delivery of sclerosant, developed over the left iliac crest. The eschar was self-limiting, with complete resolution by 6 months.
Ⅱ型内漏的最佳治疗方法仍不清楚。本报告描述了一例 82 岁多重合并症女性患者在血管内动脉瘤修复后 3 年,因囊腔扩张行Ⅱ型内漏胶栓塞治疗后出现难以进入的缺血性皮肤溃疡。栓塞剂采用 n-丁基氰基丙烯酸酯/碘化油混合物从近端位置注入,以允许血流进入内漏,因为直接囊腔穿刺是有风险的。干预治疗后 1 周,在左髂嵴上出现了一个焦痂,由于硬化剂的部分非靶向输送导致浅表坏死。焦痂自行局限,6 个月后完全愈合。